Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome

Blood. 2021 May 27;137(21):2989-2992. doi: 10.1182/blood.2020010575.
No abstract available

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antiphospholipid Syndrome / blood*
  • Antiphospholipid Syndrome / immunology
  • Biomarkers
  • Catastrophic Illness
  • Complement Activation*
  • Complement C5a / analysis*
  • Complement Inactivating Agents / therapeutic use
  • Complement Membrane Attack Complex / analysis*
  • Female
  • Humans
  • Male
  • Middle Aged

Substances

  • Antibodies, Monoclonal, Humanized
  • Biomarkers
  • Complement Inactivating Agents
  • Complement Membrane Attack Complex
  • Complement C5a
  • eculizumab